| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Internal Medicine,
College of Pharmacy, and
Department of Pathology, University of Michigan, Ann Arbor, MI 48109;
Department of Internal Medicine, University of Pennsylvania, Philadelphia, PA 19104; and
¶ State University of New York Upstate Medical University at Syracuse and Cornell University College of Veterinary Medicine, Ithaca, NY 14850
Increased monocyte/macrophage (M
) apoptosis occurs in patients with systemic lupus erythematosus (SLE) and is mediated, at least in part, by an autoreactive CD4+ T cell subset. Furthermore, autoreactive murine CD4+ T cells that kill syngeneic M in vitro induce a lupus-like disease in vivo. However, it is unclear whether increased M apoptosis in SLE per se is sufficient to accelerate/promote autoimmunity. We have investigated whether increased M apoptosis in vivo, induced by the administration of clodronate liposomes, can exacerbate the autoimmune phenotype in NZB x SWR (SNF1) lupus-prone mice, and induce autoantibody production in haplotype-matched BALB/c x DBA1 (DBF1) non-lupus-prone mice. Lupus-prone mice SNF1 mice that were treated with clodronate liposomes, but not mice treated with vehicle, developed significant increases in autoantibodies to dsDNA, nucleosomes, and the idiotypically related family of nephritic Abs IdLNF1, when compared with untreated SNF1 mice. Furthermore, clodronate treatment hastened the onset of proteinuria and worsened SNF1 lupus nephritis. When compared with vehicle-treated controls, clodronate-treated non-lupus-prone DBF1 mice developed significantly higher levels of anti-nucleosome and IdLNF1 Abs but did not develop lupus nephritis. We propose that M apoptosis contributes to the pathogenesis of autoantibody formation and organ damage through both an increase in the apoptotic load and impairment in the clearance of apoptotic material. This study suggests that mechanisms that induce scavenger cell apoptosis, such as death induced by autoreactive cytotoxic T cells observed in SLE, could play a pathogenic role and contribute to the severity of the disease.
This article has been cited by other articles:
|
|
 |
|
  D. Basu, Y. Liu, A. Wu, S. Yarlagadda, G. J. Gorelik, M. J. Kaplan, A. Hewagama, R. C. Hinderer, F. M. Strickland, and B. C. Richardson Stimulatory and Inhibitory Killer Ig-Like Receptor Molecules Are Expressed and Functional on Lupus T Cells J. Immunol., September 1, 2009; 183(5): 3481 - 3487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhao, S. G. Thacker, J. B. Hodgin, H. Zhang, J. H. Wang, J. L. Park, A. Randolph, E. C. Somers, S. Pennathur, M. Kretzler, et al. The Peroxisome Proliferator-Activated Receptor {gamma} Agonist Pioglitazone Improves Cardiometabolic Risk and Renal Inflammation in Murine Lupus J. Immunol., August 15, 2009; 183(4): 2729 - 2740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Cantaert, L De Rycke, C P Mavragani, C A Wijbrandts, T B Niewold, T Niers, B Vandooren, E M Veys, D Richel, P P Tak, et al. Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade Ann Rheum Dis, June 1, 2009; 68(6): 1022 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Martinez-Valle, E Balada, J Ordi-Ros, S Bujan-Rivas, A Sellas-Fernandez, and M Vilardell-Tarres DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features Lupus, April 1, 2009; 18(5): 418 - 423. [Abstract] [PDF]
|
|
|
|
|
|
A. Okamoto, K. Fujio, N. van Rooijen, N. H. Tsuno, K. Takahashi, H. Tsurui, S. Hirose, K. B. Elkon, and K. Yamamoto Splenic Phagocytes Promote Responses to Nucleosomes in (NZB x NZW) F1 Mice J. Immunol., October 15, 2008; 181(8): 5264 - 5271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Frisoni, L. McPhie, S.-A. Kang, M. Monestier, M. Madaio, M. Satoh, and R. Caricchio Lack of Chromatin and Nuclear Fragmentation In Vivo Impairs the Production of Lupus Anti-Nuclear Antibodies J. Immunol., December 1, 2007; 179(11): 7959 - 7966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Lu, A. Wu, L. Tesmer, D. Ray, N. Yousif, and B. Richardson Demethylation of CD40LG on the Inactive X in T Cells from Women with Lupus J. Immunol., November 1, 2007; 179(9): 6352 - 6358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Trouw, A. A. Bengtsson, K. A. Gelderman, B. Dahlback, G. Sturfelt, and A. M. Blom C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack J. Biol. Chem., September 28, 2007; 282(39): 28540 - 28548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rodriguez, C. Mold, M. Kataranovski, J. A. Hutt, L. L. Marnell, J. S. Verbeek, and T. W. Du Clos C-Reactive Protein-Mediated Suppression of Nephrotoxic Nephritis: Role of Macrophages, Complement, and Fc{gamma} Receptors J. Immunol., January 1, 2007; 178(1): 530 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Furtado, B. Pina, F. Tacke, S. Gaupp, N. van Rooijen, T. M. Moran, G. J. Randolph, R. M. Ransohoff, S. W. Chensue, C. S. Raine, et al. A Novel Model of Demyelinating Encephalomyelitis Induced by Monocytes and Dendritic Cells J. Immunol., November 15, 2006; 177(10): 6871 - 6879. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
